Or Metastatic Nras-mutant Melanoma

• CLINICAL_TRIALS research · 2026-02-27
  Clinical Trial Update: A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) [Phase 3]

  A Phase 3 trial SEACRAFT-2 evaluating naporafenib plus trametinib in NRAS-mutant melanoma is currently active but not recruiting.

• CLINICAL_TRIALS trial_result · 2020-08-12
  Clinical Trial Update: A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma [Phase 1, Phase 2]

  Phase Ib/II study investigating LEE011 (trametinib) in combination with MEK162 in NRAS-mutant melanoma has completed with posted results.